In what can be described as a timely and highly significant convergence of eggheads and policymakers in the pharmaceutical industry in Africa, the Pharmaceutical Society of Nigeria (PSN),

in collaboration with the Attorney General Alliance-Africa Programme (AGA-Africa), has rolled out strategies for safeguarding the pharmaceutical landscape in Nigeria and beyond from the nefarious activities of drug counterfeiters.

Speaking during a 2-day workshop on combating the menace of substandard and falsified medical products, held at Sheraton Hotel, Lagos, from Tuesday 25 April to Wednesday 26 April, 2023, President of the apex pharmaceutical body in Nigeria, Professor Cyril Usifoh, lauded the partnership between the PSN and AGA-Africa, while bemoaning the level of damage substandard and falsified medical products have unleashed on patients all over the world.

According to Usifoh, substandard and falsified medical products have been responsible for the deaths of over 280 million children all over the world – a development he described as absolutely unacceptable. He therefore urged pharmacists to rise to the occasion and play their roles as direct stakeholders in ensuring the safety of medicines.

While urging the government to provide the enabling incentives for stakeholders such as NAFDAC to sustain the culture of vigilance and responsiveness  which it has been known for, Usifoh applauded the food and drug regulator for its efforts so far, especially in facilitating the approval of the malaria vaccine for use in Nigeria. https://pharmanewsonline.com/psn-nafdac-pcn-others-brainstorm-on-combating-substandard-medicines-in-africa/

“Poverty and greed are some of the factors responsible for the production of substandard and falsified medical products in Africa, especially in Nigeria. Government needs to intervene urgently,” he said. https://pharmanewsonline.com/psn-nafdac-pcn-others-brainstorm-on-combating-substandard-medicines-in-africa/